Funder: Cancer Research Institute
Due Dates (Anticipated): December 2025 (Letter of Intent) | March 2026 (Full Application)
Funding Amounts: Up to $150,000 per year for 2 years (maximum $300,000 total); no indirect costs allowed.
Summary: Supports pre-clinical and translational research to advance cancer immunotherapy by bridging laboratory discoveries and clinical applications.
Key Information: Faculty (assistant professor or higher) at nonprofit institutions; global eligibility; for-profit institutions not eligible.